Literature DB >> 10600472

SNX5, a new member of the sorting nexin family, binds to the Fanconi anemia complementation group A protein.

T Otsuki1, S Kajigaya, K Ozawa, J M Liu.   

Abstract

The function of the Fanconi anemia complementation group A (FANCA) protein remains unclear. To investigate possible protein-protein interactions, we performed yeast two-hybrid screening using a FANCA fragment as bait. Sorting nexin 5 (SNX5), a new member of the human SNX family, was identified as a putative FANCA-binding protein. The interaction between FANCA and SNX5 was confirmed by immunoprecipitation studies. All members of the SNX family have a characteristic amino acid region termed the phox homology (PX) domain. Deletion mutant analysis indicated that the PX domain is not required for binding to FANCA. The SNX proteins are thought to play an important role in receptor trafficking between organelles. We found that overexpression of SNX5 increased FANCA protein levels. Northern blot analysis of SNX5 showed the presence of alternatively spliced transcripts and different expression patterns in various human cancer cell lines and normal tissues. Further studies are needed to elucidate the functional significance of FANCA and SNX5 binding; however, we speculate that FANCA may affect SNX5 traffic with cell surface receptors. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10600472     DOI: 10.1006/bbrc.1999.1731

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Identification of the functional domains of yeast sorting nexins Vps5p and Vps17p.

Authors:  Matthew N J Seaman; Hazel P Williams
Journal:  Mol Biol Cell       Date:  2002-08       Impact factor: 4.138

Review 2.  Fanconi anaemia.

Authors:  M D Tischkowitz; S V Hodgson
Journal:  J Med Genet       Date:  2003-01       Impact factor: 6.318

3.  Regulation of hematopoietic stem cell aging in vivo by a distinct genetic element.

Authors:  Hartmut Geiger; Gabriela Rennebeck; Gary Van Zant
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-23       Impact factor: 11.205

4.  Loss of renal SNX5 results in impaired IDE activity and insulin resistance in mice.

Authors:  Fengmin Li; Jian Yang; Van Anthony M Villar; Laureano D Asico; Xiaobo Ma; Ines Armando; Hironobu Sanada; Minoru Yoneda; Robin A Felder; Pedro A Jose; Xiaoyan Wang
Journal:  Diabetologia       Date:  2017-10-28       Impact factor: 10.122

Review 5.  The enigmatic endosome - sorting the ins and outs of endocytic trafficking.

Authors:  Naava Naslavsky; Steve Caplan
Journal:  J Cell Sci       Date:  2018-07-06       Impact factor: 5.285

Review 6.  Phosphoinositides in the mammalian endo-lysosomal network.

Authors:  Peter J Cullen; Jeremy G Carlton
Journal:  Subcell Biochem       Date:  2012

Review 7.  The Phox homology (PX) domain, a new player in phosphoinositide signalling.

Authors:  Y Xu; L F Seet; B Hanson; W Hong
Journal:  Biochem J       Date:  2001-12-15       Impact factor: 3.857

8.  A large family of endosome-localized proteins related to sorting nexin 1.

Authors:  R D Teasdale; D Loci; F Houghton; L Karlsson; P A Gleeson
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

9.  Clathrin isoform CHC22, a component of neuromuscular and myotendinous junctions, binds sorting nexin 5 and has increased expression during myogenesis and muscle regeneration.

Authors:  Mhairi C Towler; Paul A Gleeson; Sachiko Hoshino; Paavo Rahkila; Venus Manalo; Norio Ohkoshi; Charles Ordahl; Robert G Parton; Frances M Brodsky
Journal:  Mol Biol Cell       Date:  2004-05-07       Impact factor: 4.138

10.  The retromer coat complex coordinates endosomal sorting and dynein-mediated transport, with carrier recognition by the trans-Golgi network.

Authors:  Thomas Wassmer; Naomi Attar; Martin Harterink; Jan R T van Weering; Colin J Traer; Jacqueline Oakley; Bruno Goud; David J Stephens; Paul Verkade; Hendrik C Korswagen; Peter J Cullen
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.